Jeffrey S. Heier Ocular Therapeutix, Inc (OCUL) insider trading activity
Jeffrey S. Heier is Chief Scientific Officer of OCULAR THERAPEUTIX, INC. Currently has a direct ownership of 326,425 shares of OCUL, which is worth approximately $3.71 Million. The most recent transaction as insider was on Jan 02, 2026, when has been sold 79,112 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
326K
30.88%
3M change
21.32%
12M change
Total Value Held
$3.71 Million
Jeffrey S. Heier Transaction History
JSH
Jeffrey S. Heier
Chief Scientific Officer
Bedford,, MA